Skip to main content

Is QuilliChew ER a controlled substance?

Medically reviewed by Judith Stewart, BPharm. Last updated on Feb 13, 2024.

Official answer

by Drugs.com

Yes. QuilliChew ER (methylphenidate) is a schedule II controlled substance.

What is QuilliChew ER?

QuilliChew ER contains methylphenidate, which is a central nervous system (CNS) stimulant commonly used for the treatment of attention deficit hyperactivity disorder (ADHD).

QuilliChew ER is available as extended-release chewable tablets in 20 mg, 30 mg and 40 mg strengths making it suitable for the treatment of ADHD in patients 6 years and older.

What is a Schedule II Controlled Substance?

Drugs placed in Schedule II of the Controlled Substances Act (CSA) have a high potential for abuse and dependence.

Drugs in Schedule II have a currently accepted medical use in the United States or a currently accepted medical use with severe restrictions. Abuse of these drugs may lead to severe psychological or physical dependence.

Examples of Schedule II substances include morphine, cocaine, hydrocodone, oxycodone, fentanyl, and methylphenidate.

  • QuilliChew ER must be stored in a safe place, preferably locked, to prevent misuse.
  • QuilliChew ER must not be given to anyone else. Selling or giving away QuilliChew ER may harm others and is against the law.
  • Any unused or expired QuilliChew ER tablets should be disposed of through a medicine take-back program if available.
References

U.S. Food and Drug Administration. QuilliChew ER Product Label. Available at https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207960s005lbl.pdf [Accessed February 22, 2021]

Read next

Metilfenidato is the Spanish, Italian, and Portuguese translation for methylphenidate which may be used to treat children or adults with attention deficit hyperactivity disorder (ADHD) to help with hyperactivity and impulsive behavior, and allow them to concentrate better. Metilfenidato may also be used to treat adults with narcolepsy. Metilfenidato translates to methylphenidate. Continue reading

The main difference between Adderall and Vyvanse is that Adderall is a mixture of four different kinds of amphetamine salts (one of which is dextroamphetamine) while Vyvanse only contains one type of amphetamine salt, called lisdexamfetamine. Lisdexamfetamine gets converted into dexamphetamine once it is in the body. One advantage of Vyvanse is that it may be less likely to be abused; although it is slightly more expensive than Adderall, although both have generic forms available. Because both drugs contain amphetamines, they work in a similar way. Studies have shown that Vyvanse is just as effective as Adderall, and side effects, including the risk of dependence, are similar. Continue reading

For ADHD: In adults, Vyvanse was shown in clinical studies to improve attention at 2 hours and up to 14 hours after taking a dose. In children aged 6-12, Vyvanse was shown to start working within 1.5 hours and up to 13 hours after the morning dose. For binge eating disorder, it can take up to 12 weeks for patients to show a significant reduction in their number of binge days per week. Continue reading

Related medical questions

Drug information

Related support groups

Medical Disclaimer